Biogen
BIIB
BIIB
1,102 hedge funds and large institutions have $43.4B invested in Biogen in 2021 Q2 according to their latest regulatory filings, with 135 funds opening new positions, 324 increasing their positions, 467 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.17% less ownership
Funds ownership: 83.86% → 83.69% (-0.17%)
6% less call options, than puts
Call options by funds: $1.8B | Put options by funds: $1.91B
31% less repeat investments, than reductions
Existing positions increased: 324 | Existing positions reduced: 467
Holders
1,102
Holding in Top 10
27
Calls
$1.8B
Puts
$1.91B
Top Buyers
| 1 | +$445M | |
| 2 | +$148M | |
| 3 | +$114M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$101M |
| 5 |
HM
HealthCor Management
New York
|
+$78.4M |
Top Sellers
| 1 | -$184M | |
| 2 | -$180M | |
| 3 | -$171M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$169M |
| 5 |
SAM
Southeastern Asset Management
Memphis,
Tennessee
|
-$169M |